Cantor Fitzgerald Maintains Overweight on Teradyne, Raises Price Target to $550
Cantor Fitzgerald analyst C.J. Muse maintains Teradyne (NASDAQ: TER ) with a Overweight and raises the price target from $400 to $550.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.